Eliana Clark insider trades

Open-market stock purchases and sales by Eliana Clark, EVP, Chief Technical Officer at Intellia Therapeutics, Inc, from SEC Form 4 filings since Mar 1, 2022.

Recent trades

DateStockTradeValue
Mar 2, 2026NTLA Intellia Therapeutics, IncSold$8.4K
Mar 1, 2026NTLA Intellia Therapeutics, IncBought (not open market)—
Mar 1, 2026NTLA Intellia Therapeutics, IncBought (not open market)—
Jan 5, 2026NTLA Intellia Therapeutics, IncSold$87.6K

Companies traded

  • NTLA Intellia Therapeutics, Inc: 15 sales, last Mar 2, 2026

Get free alerts when Eliana Clark files a new trade →